United States Dermatology Drug Market Report 2017

Publisher Name :
Date: 19-Sep-2017
No. of pages: 114
Inquire Before Buying

In this report, the United States Dermatology Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Dermatology Drug in these regions, from 2012 to 2022 (forecast).

United States Dermatology Drug market competition by top manufacturers/players, with Dermatology Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- AbbVie

- Johnson & Johnson

- Bayer

- Galderma

- Bristol-Myers Squibb

- Novartis

- Pfizer

- Merz Pharma

- Valeant

- LEO Pharma

- GlaxoSmithKline

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- External Use

- Oral

- Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dermatology Drug for each application, including

- Psoriasis

- Skin Infections

- Acne

- Dermatitis

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Dermatology Drug Market Report 2017

Table of Contents
United States Dermatology Drug Market Report 2017
1 Dermatology Drug Overview
1.1 Product Overview and Scope of Dermatology Drug
1.2 Classification of Dermatology Drug by Product Category
1.2.1 United States Dermatology Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Dermatology Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 External Use
1.2.4 Oral
1.2.5 Injection
1.3 United States Dermatology Drug Market by Application/End Users
1.3.1 United States Dermatology Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Other
1.4 United States Dermatology Drug Market by Region
1.4.1 United States Dermatology Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Dermatology Drug Status and Prospect (2012-2022)
1.4.3 Southwest Dermatology Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Dermatology Drug Status and Prospect (2012-2022)
1.4.5 New England Dermatology Drug Status and Prospect (2012-2022)
1.4.6 The South Dermatology Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Dermatology Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Dermatology Drug (2012-2022)
1.5.1 United States Dermatology Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Dermatology Drug Revenue and Growth Rate (2012-2022)
2 United States Dermatology Drug Market Competition by Players/Suppliers
2.1 United States Dermatology Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Dermatology Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Dermatology Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Dermatology Drug Market Competitive Situation and Trends
2.4.1 United States Dermatology Drug Market Concentration Rate
2.4.2 United States Dermatology Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dermatology Drug Manufacturing Base Distribution, Sales Area, Product Type
3 United States Dermatology Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Dermatology Drug Sales and Market Share by Region (2012-2017)
3.2 United States Dermatology Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Dermatology Drug Price by Region (2012-2017)
4 United States Dermatology Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Dermatology Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Dermatology Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Dermatology Drug Price by Type (2012-2017)
4.4 United States Dermatology Drug Sales Growth Rate by Type (2012-2017)
5 United States Dermatology Drug Sales (Volume) by Application (2012-2017)
5.1 United States Dermatology Drug Sales and Market Share by Application (2012-2017)
5.2 United States Dermatology Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Dermatology Drug Players/Suppliers Profiles and Sales Data
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Dermatology Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
6.2.2 Dermatology Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Johnson & Johnson Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bayer
6.3.2 Dermatology Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bayer Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Galderma
6.4.2 Dermatology Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Galderma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.2 Dermatology Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.2 Dermatology Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Dermatology Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Merz Pharma
6.8.2 Dermatology Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Merz Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Valeant
6.9.2 Dermatology Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Valeant Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 LEO Pharma
6.10.2 Dermatology Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 LEO Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline
7 Dermatology Drug Manufacturing Cost Analysis
7.1 Dermatology Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dermatology Drug
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Dermatology Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dermatology Drug Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Dermatology Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Dermatology Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Dermatology Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Dermatology Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Dermatology Drug Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Dermatology Drug
Figure United States Dermatology Drug Market Size (MT) by Type (2012-2022)
Figure United States Dermatology Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure External Use Product Picture
Figure Oral Product Picture
Figure Injection Product Picture
Figure United States Dermatology Drug Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Dermatology Drug by Application in 2016
Figure Psoriasis Examples
Table Key Downstream Customer in Psoriasis
Figure Skin Infections Examples
Table Key Downstream Customer in Skin Infections
Figure Acne Examples
Table Key Downstream Customer in Acne
Figure Dermatitis Examples
Table Key Downstream Customer in Dermatitis
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Dermatology Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dermatology Drug Sales (MT) and Growth Rate (2012-2022)
Figure United States Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dermatology Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Dermatology Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Dermatology Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dermatology Drug Sales Share by Players/Suppliers
Figure 2017 United States Dermatology Drug Sales Share by Players/Suppliers
Figure United States Dermatology Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Dermatology Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Dermatology Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dermatology Drug Revenue Share by Players/Suppliers
Figure 2017 United States Dermatology Drug Revenue Share by Players/Suppliers
Table United States Market Dermatology Drug Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Dermatology Drug Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Dermatology Drug Market Share of Top 3 Players/Suppliers
Figure United States Dermatology Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dermatology Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dermatology Drug Product Category
Table United States Dermatology Drug Sales (MT) by Region (2012-2017)
Table United States Dermatology Drug Sales Share by Region (2012-2017)
Figure United States Dermatology Drug Sales Share by Region (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Region in 2016
Table United States Dermatology Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Dermatology Drug Revenue Share by Region (2012-2017)
Figure United States Dermatology Drug Revenue Market Share by Region (2012-2017)
Figure United States Dermatology Drug Revenue Market Share by Region in 2016
Table United States Dermatology Drug Price (USD/Kg) by Region (2012-2017)
Table United States Dermatology Drug Sales (MT) by Type (2012-2017)
Table United States Dermatology Drug Sales Share by Type (2012-2017)
Figure United States Dermatology Drug Sales Share by Type (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Type in 2016
Table United States Dermatology Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Dermatology Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dermatology Drug by Type (2012-2017)
Figure Revenue Market Share of Dermatology Drug by Type in 2016
Table United States Dermatology Drug Price (USD/Kg) by Types (2012-2017)
Figure United States Dermatology Drug Sales Growth Rate by Type (2012-2017)
Table United States Dermatology Drug Sales (MT) by Application (2012-2017)
Table United States Dermatology Drug Sales Market Share by Application (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Application (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Application in 2016
Table United States Dermatology Drug Sales Growth Rate by Application (2012-2017)
Figure United States Dermatology Drug Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Dermatology Drug Sales Growth Rate (2012-2017)
Figure AbbVie Dermatology Drug Sales Market Share in United States (2012-2017)
Figure AbbVie Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Dermatology Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer Dermatology Drug Sales Growth Rate (2012-2017)
Figure Bayer Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Bayer Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Galderma Basic Information List
Table Galderma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Galderma Dermatology Drug Sales Growth Rate (2012-2017)
Figure Galderma Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Galderma Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Dermatology Drug Sales Growth Rate (2012-2017)
Figure Novartis Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Novartis Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Dermatology Drug Sales Growth Rate (2012-2017)
Figure Pfizer Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Merz Pharma Basic Information List
Table Merz Pharma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merz Pharma Dermatology Drug Sales Growth Rate (2012-2017)
Figure Merz Pharma Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Merz Pharma Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Valeant Basic Information List
Table Valeant Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Valeant Dermatology Drug Sales Growth Rate (2012-2017)
Figure Valeant Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Valeant Dermatology Drug Revenue Market Share in United States (2012-2017)
Table LEO Pharma Basic Information List
Table LEO Pharma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure LEO Pharma Dermatology Drug Sales Growth Rate (2012-2017)
Figure LEO Pharma Dermatology Drug Sales Market Share in United States (2012-2017)
Figure LEO Pharma Dermatology Drug Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology Drug
Figure Manufacturing Process Analysis of Dermatology Drug
Figure Dermatology Drug Industrial Chain Analysis
Table Raw Materials Sources of Dermatology Drug Major Players/Suppliers in 2016
Table Major Buyers of Dermatology Drug
Table Distributors/Traders List
Figure United States Dermatology Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Dermatology Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Dermatology Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Type in 2022
Table United States Dermatology Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Application in 2022
Table United States Dermatology Drug Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Dermatology Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dermatology Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dermatology Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Scar Treatment Market Size, Status and Forecast 2025
    Published: 19-Jan-2018        Price: US 3300 Onwards        Pages: 94
    This report studies the global Scar Treatment market, analyzes and researches the Scar Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Smith and Nephew - Lumenis - Sonoma Pharmaceuticals - Hologic - Merz - Quantum Health - Revitol Corporation - Scarguard Labs - Suneva Medical Market segment by Regions......
  • EMEA (Europe, Middle East and Africa) Botox Market 2017 Forecast to 2022
    Published: 18-Jan-2018        Price: US 4480 Onwards        Pages: 122
    Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in EMEA mark......
  • Global Botox Market Research Report 2018
    Published: 18-Jan-2018        Price: US 2900 Onwards        Pages: 106
    In this report, the global Botox market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Botox in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - China - Japan - Southeas......
  • North America Hyaluronic Acid Dermal Filler Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 17-Jan-2018        Price: US 4480 Onwards        Pages: 124
    This report studies the Middle East Hyaluronic Acid Dermal Filler market, Hyaluronic Acid Dermal Filler are the product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour. Scope of the Report: This report focuses on the Hyaluronic Acid Dermal Filler in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type an......
  • Global Hyaluronic Acid Dermal Filler Market Professional Survey Report 2018
    Published: 16-Jan-2018        Price: US 3500 Onwards        Pages: 101
    This report studies Hyaluronic Acid Dermal Filler in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Galderma - Allergan - Merz - Sinclair - LG Life......
  • United States Onychomycosis (Tinea Unguium) Drug Market Report 2018
    Published: 16-Jan-2018        Price: US 3800 Onwards        Pages: 101
    In this report, the United States Onychomycosis (Tinea Unguium) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share ......
  • 2015-2023 World Botox Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 15-Jan-2018        Price: US 2800 Onwards        Pages: 127
    Summary Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. This report includes market status and forecast of global and majo......
  • Global Pruritus Therapeutics Market Research Report 2018
    Published: 11-Jan-2018        Price: US 3500 Onwards        Pages: 138
    Summary Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex. Market Segment as follows:......
  • 2015-2023 World Pressure Ulcer Treatment Products Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 10-Jan-2018        Price: US 2800 Onwards        Pages: 121
    Summary Pressure ulcer is an open wound on the skin. Pressure ulcer occurs due to the breakdown of skin and underlying tissues through excessive pressure on an area of the skin. Some of the symptoms of pressure ulcer are redness of the skin that worsens with time, and blisters on the area and then an open sore. Pressure ulcer commonly occur on the elbows, back of the head, buttocks, heels, shoulders, hips, ankles, and back. This report includes market status and forecast of global ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs